Skip to content
  • Saturday, 12 September 2026
  • 5:48 pm
  • Follow Us
Lab DB
  • Home
  • About Us
    • About Us
    • Affiliate Disclosure
    • Cookie Policy
    • Disclaimer
    • Privacy Policy
    • DMCA
    • Terms of Service
  • Contact Us
  • FAQ
  • Home
  • Nigerian Research Highlights Water-in-Diesel Emulsion as a Critical Breakthrough for Global Emission Reduction and Engine Efficiency
Advanced Materials Science

Nigerian Research Highlights Water-in-Diesel Emulsion as a Critical Breakthrough for Global Emission Reduction and Engine Efficiency

Nila Kartika Wati Jul 21, 2026 0

The global economy remains inextricably linked to the diesel engine, a workhorse of modern industry that powers everything from transcontinental…

Read More
Advanced Materials Science

Nigerian Researchers Unveil Water-in-Diesel Emulsion Technology as a Scalable Solution for Drastic Emission Reductions and Enhanced Engine Performance

Nila Kartika Wati Jul 11, 2026 0

In a comprehensive review that bridges the gap between mechanical engineering and environmental science, a research team from the Federal…

Read More
Advanced Materials Science

Nigerian Researchers Unveil Water-in-Diesel Emulsion Technology as a Sustainable Path to Reducing Global Engine Emissions

Nila Kartika Wati Jul 2, 2026 0

The global industrial landscape remains heavily reliant on the diesel engine, a mechanical workhorse that powers the backbone of international…

Read More
Laboratory Automation & Robotics

Insilico CEO sees potentially $2.75 billion collaboration as ‘fusing Lilly’s clinical excellence’ with Insilico’s ‘end-to-end AI engine’

Lana Keisha Jun 2, 2026 0

A transformative partnership has been forged between Insilico Medicine, a pioneer in artificial intelligence-driven drug discovery, and Eli Lilly, a…

Read More
Laboratory Automation & Robotics

Insilico CEO sees potentially $2.75 billion collaboration as ‘fusing Lilly’s clinical excellence’ with Insilico’s ‘end-to-end AI engine’

Lana Keisha May 16, 2026 0

In a landmark move poised to reshape the landscape of pharmaceutical innovation, Insilico Medicine, a pioneer in artificial intelligence (AI)-driven…

Read More
Laboratory Automation & Robotics

Insilico CEO Sees Potentially $2.75 Billion Collaboration as ‘Fusing Lilly’s Clinical Excellence’ with Insilico’s ‘End-to-End AI Engine’

Lana Keisha May 8, 2026 0

On March 29, Insilico Medicine, a pioneer in artificial intelligence (AI)-driven drug discovery and development, announced a landmark collaboration with…

Read More
Laboratory Automation & Robotics

Insilico CEO Sees Potentially $2.75 Billion Collaboration as Fusing Lilly’s Clinical Excellence with Insilico’s End-to-End AI Engine

Lana Keisha Apr 28, 2026 0

On March 29, Insilico Medicine, a pioneer in artificial intelligence (AI)-driven drug discovery and development, announced a monumental drug discovery…

Read More
Laboratory Automation & Robotics

Insilico CEO sees potentially $2.75 billion collaboration as ‘fusing Lilly’s clinical excellence’ with Insilico’s ‘end-to-end AI engine’

Lana Keisha Apr 21, 2026 0

Insilico Medicine, a pioneering company in artificial intelligence-driven drug discovery and development, has cemented a landmark global research and development…

Read More
Laboratory Automation & Robotics

Insilico CEO Sees Potentially $2.75 Billion Collaboration as ‘Fusing Lilly’s Clinical Excellence’ with Insilico’s ‘End-to-End AI Engine’

Lana Keisha Apr 13, 2026 0

On March 29, Insilico Medicine, a pioneer in artificial intelligence-driven drug discovery, announced a landmark collaboration with pharmaceutical giant Eli…

Read More
Advanced Materials Science

Federal University of Technology Owerri Researchers Identify Water-in-Diesel Emulsion as a Sustainable Solution for Global Engine Emission Reduction

Nila Kartika Wati Mar 22, 2026 0

In a comprehensive analytical study that addresses one of the most persistent challenges in mechanical engineering and environmental science, researchers…

Read More

Posts pagination

1 2
Bristol Myers Squibb and Hengrui Pharma Forge Landmark $15.2 Billion Oncology and Immunology CollaborationMolecular Switch Discovery Unlocks New Potential for Blood Stem Cell Activation and Bone Marrow TransplantsInsilico CEO sees potentially $2.75 billion collaboration as ‘fusing Lilly’s clinical excellence’ with Insilico’s ‘end-to-end AI engine’Everest Medicines Acquires Hasten Biopharmaceuticals for $250 Million to Bolster Asia Pacific Chronic Disease Portfolio and Commercial Reach
Japan’s FY26 NHI Drug Price Revision: Deeper Dive into Mechanisms and Market ImpactMEDVi Under Scrutiny: AI-Powered Telehealth Startup Faces FDA Warnings, Deceptive Marketing Allegations, and Multiple Lawsuits Despite Meteoric GrowthThe Most Favored Nation (MFN) Policy’s Unforeseen Ripple Effect: European Pharmaceutical Launches and Withdrawals PlummetLLMOps in 2026: The 10 Tools Every Team Must Have
TWiV 1287: Ancient herpesviruses and modern dementiaJohns Hopkins Researchers Discover How Fusion Genes Drive Rare Kidney Cancer Through Liquid DropletsRNA breakthrough provides hope for thousands of untreatable diseases, including cystic fibrosis, muscular dystrophy and some cancersMerck and Moderna’s cancer vaccine is customized for each patient’s tumor
YOU MAY HAVE MISSED
Microbiology & Immunology
TWiV 1287: Ancient herpesviruses and modern dementia
Lina Irawan Sep 12, 2026
Stem Cell & Regenerative Medicine
Johns Hopkins Researchers Discover How Fusion Genes Drive Rare Kidney Cancer Through Liquid Droplets
Dwi Wanna Sep 12, 2026
Biotech & Genetic Research
RNA breakthrough provides hope for thousands of untreatable diseases, including cystic fibrosis, muscular dystrophy and some cancers
Jia Lissa Sep 12, 2026
Laboratory Automation & Robotics
Merck and Moderna’s cancer vaccine is customized for each patient’s tumor
Lana Keisha Sep 12, 2026

Copyright © 2025 | Powered by WordPress | News Gadgets by ThemeArile

  • Home
  • About Us
    • About Us
    • Affiliate Disclosure
    • Cookie Policy
    • Disclaimer
    • Privacy Policy
    • DMCA
    • Terms of Service
  • Contact Us
  • FAQ